RTI Biologics' BioCleanse allografts show positive clinical results RTI Biologics announced results of a recent randomized prospective clinical study of BioCleanse-processed bone-patellar tendon-bone allografts used in anterior cruciate ligament reconstruction surgery. The study compares the clinical outcomes of BTB allografts processed using RTIís patented BioCleanse Tissue Sterilization Process with a control group consisting of aseptically-processed allografts from the three U.S. tissue banks that provide this type of allograft. Results indicate that the sterilization process, BioCleanse, did not demonstrate a statistical difference in clinical outcomes for the BTB allograft at two years. The BioCleanse process may provide surgeons with allografts clinically similar to aseptically-processed allograft tissue with the benefit of addressing donor-to-recipient disease.
News For RTIX From The Last 14 Days
Check below for free stories on RTIX the last two weeks.